MENS Stock Summary and Trading Ideas (Jyong Biotech Ltd. - | NASDAQ:MENS)

Jyong Biotech Ltd is a science-driven biotechnology company based in Taiwan and is committed to developing and commercializing innovative and differentiated new drugs (plant-derived) mainly specializing in the treatment of urinary system diseases, with an initial focus on the markets of the U.S., the EU and Asia (primarily Taiwan and mainland China). It has been dedicated to the research and development of new drugs with high safety and efficacy. It has been developing a series of drug candidates, including one core drug candidate at NDA stage, one clinical-stage key drug candidate and other preclinical-stage drug candidates.

Jyong Biotech Ltd. - trades on the NASDAQ stock market under the symbol MENS.

As of December 19, 2025, MENS stock price declined to $3.17 with 1,125,451 million shares trading.

MENS has a beta of 4.62, meaning it tends to be more sensitive to market movements. MENS has a correlation of 0.02 to the broad based SPY ETF.

MENS has a market cap of $241.39 million. This is considered a Small Cap stock.

The top ETF exchange traded funds that MENS belongs to (by Net Assets): ONEQ.

MENS support price is $2.90 and resistance is $3.76 (based on 1 day standard deviation move). This means that using the most recent 20 day stock volatility and applying a one standard deviation move around the stock's closing price, stastically there is a 67% probability that MENS shares will trade within this expected range on the day.